196960-06-2

Basic information

• Product Name: 4-(2,3-difluorophenyl)cyclohexan-1-one
• Synonyms: 4-(2,3-difluorophenyl)cyclohexan-1-one
• CAS NO: 196960-06-2
• Molecular Weight: 210.223
• Mol File: 196960-06-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-(2,3-difluorophenyl)cyclohexan-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2,3-difluorophenyl)cyclohexan-1-one(196960-06-2)
• EPA Substance Registry System: 4-(2,3-difluorophenyl)cyclohexan-1-one(196960-06-2)

Safety Data

• Hazardous Substances Data: 196960-06-2(Hazardous Substances Data)

Upstream product

• 367-11-3 ortho-difluorobenzene 
• 680596-79-6 4,4,5,5-tetramethyl-2-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-1,3,2-dioxaborolane 
• 170011-47-9 1,4-dioxaspiro[4.5]dec-7-en-8-yl trifluoromethanesulfonate 
• 196960-05-1 8-(2,3-difluorophenyl)-1,4-dioxaspiro[4.5]dec-7-ene 
• 38573-88-5 1-bromo-2,3-difluorobenzene 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 1283606-46-1 8-(2,3-difluorophenyl)-1,4-dioxaspiro[4.5]decane 

Downstream Products

• 1338448-92-2 1-butoxy-4-[4-(2,3-difluorophenyl)cyclohex-1-enyl]-2,3-difluorobenzene 

Relevant articles and documents

NOVEL 5 or 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES

Disclosed herein are 5 or 8-substituted imidazo [1, 5-a] pyridines and pharmaceutical compositions comprising at least one such 5 or 8-substituted imidazo [1, 5-a] pyridines, processes for the preparation thereof, and the use thereof in therapy. Disclosed herein are certain 5 or 8-substituted imidazo [1, 5-a] pyridines that can be useful for inhibiting indoleamine 2, 3-dioxygenase and/or tryptophane 2, 3-dioxygenase and for treating diseases or disorders mediated thereby.

SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF

Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist act